Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Open-label, Pharmacokinetic (PK) Study of a Single Intra-articular Administration of TLC599 in Subjects With Mild to Moderate Osteoarthritis of the Knee

NCT03754049 is registered in ClinicalTrials.gov with Taiwan Liposome Company as lead sponsor.

NCT NCT03754049
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03754049 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Open-label, Pharmacokinetic (PK) Study of a Single Intra-articular Administration of TLC599 in Subjects With Mild to Moderate Osteoarthritis of the Knee
Lead sponsor
Taiwan Liposome Company
Phase
Phase 2
Overall status
Completed
Start date
January 21, 2019
Completion date
November 7, 2023
Enrollment
102 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis of the knee